Annabelle Ayame Okada

8PUBLICATIONS
22CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsVenereologyOptical technologyRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 10, 2025
A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning.

Matthias Gutfleisch, Britta Heimes-Bussmann, Sökmen Aydin

|Mar 14, 2024
Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial.

Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa

|Nov 11, 2022
Automated Quantitative Analysis of Anterior Segment Inflammation Using Swept-Source Anterior Segment Optical Coherence Tomography: A Pilot Study.

Hiroshi Keino, Takuto Aman, Ryota Furuya

|Oct 24, 2022
COVID-19 vaccination-related intraocular inflammation in Japanese patients.

Makiko Nakayama, Annabelle A Okada, Isami Hayashi

|May 03, 2022
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup.

Annabelle A Okada, Kanji Takahashi, Masahito Ohji

|Feb 02, 2021
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure.

Jean-François Korobelnik, Anat Loewenstein, Bora Eldem

Pageof 2

Frequent Collaborators

1 joint publications

Massimo Accorinti

1 joint publications

Justine R Smith

1 joint publications

Marta Gilardi

1 joint publications

Jean-François Korobelnik